215 related articles for article (PubMed ID: 26965998)
1. Jak-STAT3 pathway triggers DICER1 for proteasomal degradation by ubiquitin ligase complex of CUL4A(DCAF1) to promote colon cancer development.
Ren W; Shen S; Sun Z; Shu P; Shen X; Bu C; Ai F; Zhang X; Tang A; Tian L; Li G; Li X; Ma J
Cancer Lett; 2016 Jun; 375(2):209-220. PubMed ID: 26965998
[TBL] [Abstract][Full Text] [Related]
2. Autophagic degradation of SQSTM1 inhibits ovarian cancer motility by decreasing DICER1 and AGO2 to induce MIRLET7A-3P.
Liao CC; Ho MY; Liang SM; Liang CM
Autophagy; 2018; 14(12):2065-2082. PubMed ID: 30081720
[TBL] [Abstract][Full Text] [Related]
3. Induction of metastatic potential by TrkB via activation of IL6/JAK2/STAT3 and PI3K/AKT signaling in breast cancer.
Kim MS; Lee WS; Jeong J; Kim SJ; Jin W
Oncotarget; 2015 Nov; 6(37):40158-71. PubMed ID: 26515594
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-1299 is a negative regulator of STAT3 in colon cancer.
Wang Y; Lu Z; Wang N; Zhang M; Zeng X; Zhao W
Oncol Rep; 2017 Jun; 37(6):3227-3234. PubMed ID: 28498395
[TBL] [Abstract][Full Text] [Related]
5. Assembly with the Cul4A-DDB1DCAF1 ubiquitin ligase protects HIV-1 Vpr from proteasomal degradation.
Le Rouzic E; Morel M; Ayinde D; Belaïdouni N; Letienne J; Transy C; Margottin-Goguet F
J Biol Chem; 2008 Aug; 283(31):21686-92. PubMed ID: 18524771
[TBL] [Abstract][Full Text] [Related]
6. DICER1, DROSHA and miRNAs in patients with non-small cell lung cancer: implications for outcomes and histologic classification.
Díaz-García CV; Agudo-López A; Pérez C; López-Martín JA; Rodríguez-Peralto JL; de Castro J; Cortijo A; Martínez-Villanueva M; Iglesias L; García-Carbonero R; Fresno Vara JA; Gámez-Pozo A; Palacios J; Cortés-Funes H; Paz-Ares L; Agulló-Ortuño MT
Carcinogenesis; 2013 May; 34(5):1031-8. PubMed ID: 23349018
[TBL] [Abstract][Full Text] [Related]
7. Cullin 4A (CUL4A), a direct target of miR-9 and miR-137, promotes gastric cancer proliferation and invasion by regulating the Hippo signaling pathway.
Deng J; Lei W; Xiang X; Zhang L; Lei J; Gong Y; Song M; Wang Y; Fang Z; Yu F; Feng M; Sun Z; Chen J; Zhan Z; Xiong J
Oncotarget; 2016 Mar; 7(9):10037-50. PubMed ID: 26840256
[TBL] [Abstract][Full Text] [Related]
8. The MYCN-HMGA2-CDKN2A pathway in non-small cell lung carcinoma--differences in histological subtypes.
Eide HA; Halvorsen AR; Bjaanæs MM; Piri H; Holm R; Solberg S; Jørgensen L; Brustugun OT; Kiserud CE; Helland Å
BMC Cancer; 2016 Feb; 16():71. PubMed ID: 26858029
[TBL] [Abstract][Full Text] [Related]
9. Signal transducer and activator of transcription 3 inhibition enhances vemurafenib sensitivity in colon cancers harboring the BRAF
Wang K; Li Y; Song N; Che X; Hou K; Xu L; Bai M; Wang Q; Wang Y; Zhou Y; Cao M; Liu Y; Zhang J
J Cell Biochem; 2019 Apr; 120(4):5315-5325. PubMed ID: 30320916
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of CUL4A in human prostate cancer.
Liu G; Zhu Z; Lang F; Li B; Gao D
Tumour Biol; 2015 Nov; 36(11):8553-8. PubMed ID: 26036759
[TBL] [Abstract][Full Text] [Related]
11. CUL4A facilitates hepatocarcinogenesis by promoting cell cycle progression and epithelial-mesenchymal transition.
Pan Y; Wang B; Yang X; Bai F; Xu Q; Li X; Gao L; Ma C; Liang X
Sci Rep; 2015 Nov; 5():17006. PubMed ID: 26593394
[TBL] [Abstract][Full Text] [Related]
12. IL-32θ inhibits stemness and epithelial-mesenchymal transition of cancer stem cells via the STAT3 pathway in colon cancer.
Bak Y; Kwon T; Bak IS; Hong J; Yu DY; Yoon DY
Oncotarget; 2016 Feb; 7(6):7307-17. PubMed ID: 26824417
[TBL] [Abstract][Full Text] [Related]
13. Dicer1 Phosphomimetic Promotes Tumor Progression and Dissemination.
Aryal NK; Pant V; Wasylishen AR; Rimel BJ; Baseler L; El-Naggar AK; Mutch DG; Goodfellow PJ; Arur S; Lozano G
Cancer Res; 2019 May; 79(10):2662-2668. PubMed ID: 30914430
[No Abstract] [Full Text] [Related]
14. Functional requirement of dicer1 and miR-17-5p in reactive astrocyte proliferation after spinal cord injury in the mouse.
Hong P; Jiang M; Li H
Glia; 2014 Dec; 62(12):2044-60. PubMed ID: 25043492
[TBL] [Abstract][Full Text] [Related]
15. XIAP facilitates breast and colon carcinoma growth via promotion of p62 depletion through ubiquitination-dependent proteasomal degradation.
Huang X; Wang XN; Yuan XD; Wu WY; Lobie PE; Wu Z
Oncogene; 2019 Feb; 38(9):1448-1460. PubMed ID: 30275562
[TBL] [Abstract][Full Text] [Related]
16. Distinct expression pattern of Dicer1 correlates with ovarian-derived steroid hormone receptor expression in human Fallopian tubes during ovulation and the midsecretory phase.
Shao R; Norström A; Weijdegård B; Egecioglu E; Fernandez-Rodriguez J; Feng Y; Stener-Victorin E; Brännström M; Billig H
J Clin Endocrinol Metab; 2011 May; 96(5):E869-77. PubMed ID: 21346072
[TBL] [Abstract][Full Text] [Related]
17. IL-6 Inhibits Starvation-induced Autophagy via the STAT3/Bcl-2 Signaling Pathway.
Qin B; Zhou Z; He J; Yan C; Ding S
Sci Rep; 2015 Nov; 5():15701. PubMed ID: 26549519
[TBL] [Abstract][Full Text] [Related]
18. Effect of Rhizoma paridis total saponins on apoptosis of colorectal cancer cells and imbalance of the JAK/STAT3 molecular pathway induced by IL-6 suppression.
Teng WJ; Chen P; Zhu FY; Di K; Zhou C; Zhuang J; Cao XJ; Yang J; Deng LJ; Sun CG
Genet Mol Res; 2015 May; 14(2):5793-803. PubMed ID: 26125778
[TBL] [Abstract][Full Text] [Related]
19. STAT3 activation in infection and infection-associated cancer.
Lu R; Zhang YG; Sun J
Mol Cell Endocrinol; 2017 Aug; 451():80-87. PubMed ID: 28223148
[TBL] [Abstract][Full Text] [Related]
20. IL-6 mediates the signal pathway of JAK-STAT3-VEGF-C promoting growth, invasion and lymphangiogenesis in gastric cancer.
Zhao G; Zhu G; Huang Y; Zheng W; Hua J; Yang S; Zhuang J; Ye J
Oncol Rep; 2016 Mar; 35(3):1787-95. PubMed ID: 26750536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
